2002 Nobel Prize in Physiology or Medicine — Brenner, Horvitz, and Sulston Uncover the Grammar of Apoptosis with C. elegans

What You Will Learn in This Article

The 2002 Nobel Prize in Physiology or Medicine was awarded to three scientists who used the seemingly insignificant nematode Caenorhabditis elegans, just 1 mm in length, as a model organism to elucidate the genetic program of apoptosis (programmed cell death), the process by which cells precisely execute their own demise. Sydney Brenner established this worm as a model organism, John Sulston meticulously mapped the complete cell lineage of the worm under a microscope, and Robert Horvitz identified the ced genes responsible for programmed cell death through genetic screening. Together, their discoveries revealed that apoptosis is a graceful shutdown protocol in the operating system of life, and the components of this process, including caspases and Bcl-2, have been linked to humans and now form the foundation for the treatment of leukemia, neurodegenerative diseases, and autoimmune diseases.

A Story Different from Common Sense — Death of Cells is Essential in the Process of Body Formation

The common understanding that "cells die when they become sick or injured" only captures half of the truth about cell death. More precisely, even healthy cells that are not damaged will kill themselves at a predetermined time and in a predetermined manner. The disappearance of webbing between fingers, the loss of more than half of the neurons initially formed in the fetal brain, and the immune system's elimination of T cells that react to self-antigens to prevent autoimmunity—all are due to apoptosis, the cell's self-destruction program.

This death is clean. Unlike necrosis, where the cell membrane ruptures and its contents leak out, apoptosis involves the cell neatly packaging its components so that neighboring phagocytes can quietly remove them. In terms of a computer system, this is a graceful shutdown. Closing file handles, flushing the cache, releasing locks, sending a termination signal to the parent process, and removing itself from the process table—the cell performs exactly these steps.

The fact that the first components of this program were discovered in a laboratory using worms, living on a petri dish just 1 mm in diameter, is one of the most elegant twists in 20th-century biological science.

The Zeitgeist — Between the Red Devils and SARS

In 2002, South Korea remembered the year as the World Cup year. The tournament, co-hosted by South Korea and Japan from May 31 to June 30, saw Guus Hiddink's Korean team defeat Poland, the United States, Portugal, Italy, and Spain in succession, achieving an unprecedented run to the semi-finals. Millions of "Red Devils" cheered from Seoul City Hall to Haeundae Beach in Busan. In September, the North and South Korean delegations entered the opening ceremony together at the Busan Asian Games. On December 19, Roh Moo-hyun was elected president. This was the first time that a cyber campaign created by the internet fan club "Noh Sa Mo" led to victory in a presidential election.

The world moved to a different rhythm. The circulation of euro banknotes began on January 1, 2002, marking the start of a new era in which the 12 EU countries could make payments in a single currency. The United States escalated tensions with Iraq after 9/11 and began a countdown to war, and former President Carter received the Nobel Peace Prize for his efforts, including his visit to North Korea. And in November, the first case of SARS (Severe Acute Respiratory Syndrome) was reported in Guangzhou, China. The rehearsal for the coronavirus pandemic that would shake the world the following year began quietly, but at the time, the world was unaware of its magnitude.

Life science had moved past the early days of the open science movement. Following the release of the draft human genome in early 2001, John Sulston's British Genome Team strongly advocated the principle that "the genome is a common heritage of humanity." In response to Celera Genomics' attempt to patent the genome, Sulston adhered to the principle of freely releasing data to a public database every night. The Nobel Committee's invitation of the three laureates was primarily due to the discovery of apoptosis, but the underlying value of the public nature of science, as symbolized by Sulston, also played a role in the early 21st century.

At this time, Korean life science began to participate in the international trends in real time. C. elegans laboratories were established at KAIST, Seoul National University, and Yonsei University, and a few years later, an era began in which research papers on apoptosis involving Korean researchers were published in international academic journals.

Biographical Narratives — The Man Who Passed the Baton from E. coli to Worms, the Man Who Sat in Front of the Microscope Every Night

Sydney Brenner (1927–2019) was born in South Africa. He grew up in a Jewish immigrant family and is known for having used the library as his personal study. He studied medicine and science at the University of Witwatersrand in Johannesburg, received his Ph.D. from Oxford, and then joined the MRC Molecular Biology Laboratory in Cambridge. Here, he conducted the 1961 experiment with Francis Crick that demonstrated that the genetic code is based on triplets (codons). This achievement alone would have made him a Nobel Prize candidate.

Brenner's turning point came around 1963. "The era of E. coli is coming to an end, and the era of studying the genetics of multicellular organism development is about to begin." He set the following conditions: the organism should have a small number of cells so that individual cells can be tracked, its body should be transparent so that the inside can be seen under a microscope, it should have a short generation time, genetic crosses should be easy, and it should be able to be stored frozen in a refrigerator. The worm met all these conditions—the nematode C. elegans. In a 1974 paper, Brenner proposed that this worm be used as a model organism for multicellular biology, and within a few years, dozens of laboratories adopted it. Brenner ushered in the era of multicellular genetics.

John Sulston (1942–2018) was a British chemist who joined Brenner's laboratory. He took on the task that others did not want to do—tracking every cell in the adult worm under a microscope and completely recording which cell each cell originated from at which time and what happened to it. From the late 1970s to the early 1980s, he sat in front of a microscope for 10 to 12 hours a day, observing live worms. The result was an astonishing map. The body cells of the adult C. elegans consist of exactly 959 cells, plus a few germ cells. And a surprising discovery—that exactly 131 of the 1090 cells born during development undergo programmed cell death at a predetermined time and in a predetermined location. This death of 131 cells was not an accident but a program. Sulston later led the British Human Genome Project, playing a crucial role in protecting the genome as a public resource, and became a symbol of open science in the late 20th century.

Robert Horvitz (1947–) was born in Chicago, USA, and earned his B.S. at MIT and his Ph.D. at Harvard, after which he did postdoctoral research in Brenner's lab. He then established his own laboratory as a professor at MIT and asked a new question. "There must be genes responsible for the 131 programmed cell deaths. What happens to mutants in which these genes are broken?" His screening strategy was similar to that of Hartwell. He identified mutants in which cells that should have died due to failed apoptosis survived and mapped the causative genes. The genes he found were the ced (cell death abnormal) family.

• ced-3: a protease (protein-degrading enzyme) that executes apoptosis. The evolutionary ancestor of the human caspase family.
• ced-4: an adapter protein that activates ced-3. Homologous to human Apaf-1.
• ced-9: a brake that inhibits ced-3/ced-4. Homologous to the human Bcl-2 family of tumor suppressor genes.

These three genes alone explained all 131 programmed cell deaths in C. elegans. The more surprising result was that when the human equivalents of these genes were introduced into the worm, or when the worm genes were introduced into human cells, they functioned and were compatible. Just like the cell cycle, apoptosis was also a highly conserved program in evolutionary terms.

Key Achievements — The Apoptosis Protocol in a Computer Science Framework

If we model apoptosis as a software protocol, it can be divided into three layers:

• Decision Layer: The cell comprehensively judges whether to choose apoptosis. Inputs include lack of growth factors, persistent DNA damage, accumulation of misfolded proteins, recognition of self-antigens, and the pre-programmed schedule during development.
• Activation Layer: Once the decision is made, the inhibitor (ced-9/Bcl-2) is released, and the adapter (ced-4/Apaf-1) summons the executors.
• Execution Layer: The executors (ced-3/caspases) cleave dozens of target proteins within the cell. DNA cleavage, cell membrane remodeling, cytoplasmic condensation, and cell fragmentation proceed in a defined sequence.

The key to this protocol is precision. The execution layer is always present in the cell in a standby state. Caspases are present as procaspases (pro-enzymes) before activation and are not active on their own. When an activation signal arrives, they cleave each other, activating each other, and this reaction amplifies explosively, making it irreversible. This is similar to a thread receiving a kill signal, executing all the cleanup routines, and completely terminating the process.

It is also important that inhibitors and executors always coexist in a balanced state. The Bcl-2 family consists of inhibitors (ced-9) and promoters (ced-4-like adapters) that form heterodimers with each other, and this balance is tilted depending on the cell's state. When the balance shifts towards the execution side, the outer mitochondrial membrane loses its permeability, and cytochrome c is released into the cytoplasm. Cytochrome c binds to the adapter Apaf-1, forming an active complex called the apoptosome, which initiates the caspase cascade. This is an architecture similar to multiple threads sharing a monitor, but when a certain condition is met, a kill switch is activated.

We should also point out the limitations of this analogy. Unlike software processes, actual cells have a grace period after the start of apoptosis during which it can be reversed. After the caspase downstream stages, it cannot be reversed, but in the early stages, apoptosis can be canceled by reactivating the inhibitor or re-supplying growth factors. This is a characteristic not found in pure software processes. Cells are alive even while they are dying, and they have a gray area between living and dying.

Why It Matters: From a Worm's Parts List to Human Therapeutics

The discoveries of the three laureates have branched into two major streams: one for cancer therapeutics and the other for understanding neurodegenerative diseases.

Cancer is a disease of failed apoptosis. If tumor cells, damaged by radiation or chemotherapy, fail to die, it means that a component of their apoptosis program is broken. Bcl-2 overexpression is a prime example. In chronic lymphocytic leukemia (CLL), Bcl-2 is often overexpressed, keeping the brakes on. This led to the development of venetoclax – a Bcl-2 inhibitor from the BH3 mimetic family. It is a small molecule drug that mimics the interaction between Bcl-2 and pro-apoptotic factors, releasing the brakes. Approved for CLL in 2016 and expanded to acute myeloid leukemia in 2018. Together with Hartwell's CDK inhibitor family, it forms the two pillars of 21st-century targeted cancer therapies.

In neurodegenerative diseases, the opposite is the problem. In Alzheimer's, Parkinson's, and Huntington's diseases, excessive apoptosis of neurons accelerates the progression of the disease. In this direction, the development of caspase inhibitors is actively pursued. However, the strategy of inhibiting apoptosis in the nervous system carries the risk of cancer cells surviving, so tissue-specific drug delivery is crucial. Although this field has experienced several clinical failures in the past 20 years, the principle that apoptosis regulation is a key axis of neuroprotection remains unshaken.

The power of model organisms is also a significant legacy of this story. The methodologies of developmental genetics, which began with a single C. elegans and expanded to Drosophila, zebrafish, and mice, have led to several Nobel Prizes in the following 20 years. RNA interference (2006 Nobel Prize, Fire and Mello) was discovered in C. elegans, and autophagy (2016 Osawa) also gained significant traction from yeast and C. elegans experiments, while olfactory receptor genes (2004 Axel and Buck) inherited the spirit of Brenner's model organism genetics.

John Sulston's legacy lies in a slightly different layer. The cell lineage map he created is still the first diagram in developmental biology textbooks. However, his greater legacy is the practice of the open science principle of "the genome is a common heritage of humanity." The fact that the Human Genome Project, even amidst patent competition with Celera, freely released data to a public database every night was due to Sulston's team upholding this principle. The fact that we can freely download and use human genome data for research today is the result of this effort.

It is astonishing from an evolutionary perspective. Humans and C. elegans are two lineages that diverged from a common ancestor approximately 600 million years ago. Yet, in this moment, the components that our cells use to decide and execute apoptosis – caspases, Bcl-2, Apaf-1 – are evolutionary homologs of the worm, and they largely function even when exchanged. The program that determines the life and death of cells was established in the early evolution of eukaryotic multicellular organisms and has remained largely unchanged since then.

The fact that the story that began with Brenner's single worm has created a grammar for understanding human death reaffirms the long-standing virtue of science: learning big things from small ones. If the first century ended with the organization of the cell cycle, the second year of the new century has opened up the field of cell death.

→ Previous: 2001 Nobel Prize in Physiology or Medicine → Next: 2003 Nobel Prize in Physiology or Medicine